Novo Nordisk lines up for May Alzheimer's trial

According to database Clinical Trials, Novo Nordisk will launch clinical trials for the company's diabetes drug semaglutide in tablet form as a possible treatment for Alzheimer's in end-May.

Board on new Orphazyme CEO: He has the management style we want

Orphazyme's newly appointed CEO is of a different build than his predecessor, Kim Stratton, as his management style is more transparent and inclusive, according to Vice Chairman Bo Jesper Hansen, who is excited that the new top exec is moving to Denmark and already learning the language.


Fraudsters offer EU vaccines

The black market for vaccine doses in the EU is rapidly growing with both fraudsters and companies claiming to sell vaccines.

Orphazyme recruits new CEO

Just over two months after Orphazyme bid former CEO Kim Stratton farewell, the firm has found her replacement at US biotech firm Amgen.

Latest news

See all jobs